Epinephrine 0.3 MG auto-inject 2S
Ended Awarded
- Contract number
- SPE2DB26FATXD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,203
Award facts
- Contract value 100% obligated
- $2,202.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,202.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector (2 units). The award, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. Performance will be executed in Conshohocken, Pennsylvania.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. The parent contract, valued at $499,999,999 and extending through December 31, 2036, positions DMS Pharmaceutical Group as a critical pharmaceutical supplier supporting military healthcare operations globally. The company's extensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, and emergency medications including epinephrine auto-injectors, demonstrating its capability to fulfill the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FATXD?
SPE2DB26FATXD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DB26FATXD worth?
The government has obligated $2,203 on SPE2DB26FATXD.
Is contract SPE2DB26FATXD an order under another contract?
Yes. SPE2DB26FATXD is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATXD competed?
The extent of competition for SPE2DB26FATXD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award